0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorials |

MYELOFIBROSIS ( PANMYELOSIS ) IN HIROSHIMA

JAMA. 1964;189(10):767-768. doi:10.1001/jama.1964.03070100061015.
Text Size: A A A
Published online

Myelofibrosis—a disease (or diseases) with variable degrees of anemia, splenomegaly, fibrotic bone marrow, and myeloid metaplasia—eludes precise definition. Theories on pathogcnesis range from necrobiosis (due to the toxic action of benzene, radioactive phosphorus, radium, and other agents) and primary bone-marrow failure (in which myeloid metaplasia is viewed as a compensatory process), to the current, widely held theory that it is but one of a group of myeloproliferative disorders. Proponents of this latter view regard intramedullary and extramedullary changes as stemming from a common "myelostimulatory factor." Depending on the phase of the disease, or the form it takes in a particular patient, the myeloproliferative disorder might be manifested as polycythemia vera, myelogenous leukemia, erythroleukemia of di Guglielmo, or myelofibrosis.

The so-called myelostimulatory factor, having also eluded precise definition, has remained, to a large extent, an abstraction, a convenient rack which can accommodate many hats. However, Anderson, Hoshino, and Yamamoto,1 in

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();